marion powder and solvent for solution for i/m injection
anfarm hellas s.a. - ceftriaxone (ceftriaxone sodium) - powder and solvent for solution for i/m injection - 1000mg
marion powder for solution for injection/infusion
anfarm hellas s.a. - ceftriaxone (ceftriaxone sodium) - powder for solution for injection/infusion - 1000mg
aciclovir 25mg/ml concentrate for solution for infusion
pfizer healthcare ireland - aciclovir sodium - concentrate for solution for infusion - 25 milligram(s)/millilitre - nucleosides and nucleotides excl. reverse transcriptase inhibitors; aciclovir
ceftriaxone powder for solution for injection
cr gosun pharma - ceftriaxone (ceftriaxone sodium) - powder for solution for injection - 1000mg
ceftriaxone pharmsol 2 g powder for solution for infusion
pharmsol europe limited the victoria centre unit 2, lower ground floor, valletta road, mosta mst 9012 , malta - ceftriaxone sodium - powder for solution for infusion - ceftriaxone sodium 2 gram(s) - antibacterials for systemic use
ceftriaxone pharmsol 1000 mg powder for solution for injection/infusion
pharmsol europe limited the victoria centre unit 2, lower ground floor, valletta road, mosta mst 9012 , malta - ceftriaxone - powder for solution for injection/infusion - ceftriaxone 1000 mg - antibacterials for systemic use
ceftriaxone venus pharma 1g powder for solution for injection or infusion
venus pharma gmbh am bahnhof 1-3, werne, d 59368, germany - powder for solution for injection/infusion - ceftriaxone 1 g - antibacterials for systemic use
ceftriaxone venus pharma 2g powder for solution for injection or infusion
venus pharma gmbh am bahnhof 1-3, werne, d 59368, germany - powder for solution for injection/infusion - ceftriaxone 2 g - antibacterials for systemic use
amlyo 75 mg pulver für ein konzentrat zur herstellung einer infusionslösung
ceftriaxone- ceftriaxone sodium injection, powder, for solution
samson medical technologies, llc - ceftriaxone sodium (unii: 023z5br09k) (ceftriaxone - unii:75j73v1629) - ceftriaxone 100 g - to reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection and other antibacterial drugs, ceftriaxone for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. ceftriaxone for injection is indicated for the treatment of the following infections when caused by susceptible bacteria: lower respiratory tract infections caused by streptococcus pneumoniae, staphylococcus aureus, haemophilus influenzae, haemophilus parainfluenzae, klebsiella pneumoniae, escherichia coli, enterobacter aerogenes, proteus mirabilis or serratia marcescens . skin and skin structure infections caused by staphylococcus aureus, staphylococcus epi